Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    NGM Forward P/E

    As of 2025-07-09, the Forward P/E of NGM Biopharmaceuticals Inc (NGM) is N/A.

    Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

    NGM Forward P/E - Peers Comparison
    TickerNameValue
    ACB.TOAurora Cannabis Inc18.09
    ACRG.A.U.CNAcreage Holdings Inc-
    AMPHAmphastar Pharmaceuticals Inc7.06
    ANIPANI Pharmaceuticals Inc9.76
    AVDLAvadel Pharmaceuticals PLC45.87
    AYR.A.CNAyr Wellness Inc-
    BDSIBioDelivery Sciences International Inc20.45
    CORTCorcept Therapeutics Inc47.61
    CWEB.TOCharlotte's Web Holdings Inc-
    GUD.TOKnight Therapeutics Inc106.06
    HARV.CNHarvest Health & Recreation Inc-
    HEXO.TOHexo Corp-
    HITI.VHigh Tide Inc-
    HRMYHarmony Biosciences Holdings Inc9.51
    INVAInnoviva Inc27.4
    KALAKALA BIO Inc-
    LHS.CNLiberty Health Sciences Inc-
    LTUSLotus Pharmaceuticals Inc-
    MRNSMarinus Pharmaceuticals Inc-
    OGI.TOOrganiGram Holdings Inc-
    PCRXPacira Biosciences Inc8.27
    SIGASIGA Technologies Inc10.1
    SNDLSNDL Inc-
    SUPNSupernus Pharmaceuticals Inc18.17
    TBPHTheravance Biopharma Inc-
    TXMDTherapeuticsMD Inc3.31
    VRCAVerrica Pharmaceuticals Inc-
    ZGNXZogenix Inc-
    Tickers added to watchlist